The firm will advance an exosome isolation technology that it says allows for the capture of exosomes more efficiently and sensitively than existing platforms.
The system combines sample preparation technology capable of amplifying tens of thousands of locations in the genome with next-generation sequencing.
The researchers are working to develop portable sequencing solutions for outbreak surveillance and infectious disease diagnostics.
Startup TwinStrand Biosciences has licensed the method and is working on developing targeted assays, including for early detection of ovarian cancer.
The startup is launching an instrument that will process up to 10,000 single cells for DNA sequencing as well as a panel that will target AML genes.
The deal covers IncellDx's single-cell immune-oncology and oncology diagnostic products including its single-cell PD-L1 assay.
The team tested 21 protocols for extracting DNA from human fecal microbiome samples to recommend one to improve comparability between studies.
Under an NIH grant, the firm plans to develop its Chicago method to analyze fecal metagenomic samples without relying on first culturing the bacteria.
Lexogen has commercialized the method, which involves labeling newly synthesized RNA, and said it would have applications in drug discovery pipelines.
Hangzhou Chengyuan Genomics will provide single-cell analysis services and sell 1CellBio's InDrop instrument, reagents, and kits in China.
The firms will comarket AATI's automated CE systems for quality control analysis of nucleic acids in Illumina's next-generation sequencing workflows.
The companies will market Angle's Parsortix system for harvesting circulating tumor cells with Qiagen's liquid biopsy product portfolio.
The Ann Arbor-based biotech startup will use the funding to develop its microbubble technology that allows for removal of biomolecules from biological samples.
The firm plans to use the funding to expand commercial sales efforts, advance CDx partnerships, build its regulatory infrastructure, and explore new R&D avenues.
The project aims to developa system to automate the coring of tumor samples based on identified targets for DNA and RNA extraction.
The company also disclosed that it dropped plans for a $12.5 million offering of stock and warrants following a recent reverse stock split.
The companies will integrate Cambridge's TrueMethyl technology for oxidative bisulfite sequencing with NuGen's sequencing library preparation kits.
VWR will act as the exclusive distributor for Biocept's liquid biopsy blood collection tubes everywhere in the world except China.
Bio-Rad claims that 10x Genomics infringes on patents it holds related to emulsion formation in microfluidics chips.
The USC spinout is also developing nanoparticles for targeted sequencing, biomolecule isolation, and other applications.
Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.
Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.
Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.
In Science this week: gut microbiome influences liver cancer growth, spread; and more.